Storied Canadian manufacturer, Advanced Cyclotron Systems, joins the CNIC

TORONTO – March 31, 2021 – Advanced Cyclotron Systems Inc. (ACSI), a world leader in the design and manufacturing of cyclotron equipment, including PET and SPECT radioisotope production cyclotrons, will join the Canadian Nuclear Isotope Council (CNIC), further cementing the industry association as the pre-eminent representative of the Canadian Isotope sector.

“Over the past two-and-half years the CNIC has worked hard to expand its membership to ensure it is truly a Pan-Canadian representative of the entire isotope supply chain from coast to coast,” said James Scongack, Chair of the CNIC.

“With ACSI as the newest member, the CNIC is gaining a global frontrunner in cyclotron production and truly a global leader in the international isotope sector. ACSI has been critical to helping Canada remain at the forefront of this industry and will continue to be a critical partner in helping the CNIC strengthen Canada’s isotope ecosystem.”

ACSI has a long and storied history in Canada. Over 40 years ago its affiliated company EBCO was contracted to help build the TRI-University Meson Facility (TRIUMF), Canada’s national laboratory for particle and nuclear physics, a 500 MeV particle accelerator. Out of that relationship came the technological transfer and subsequent commercialization of TRIUMF’s technology in 1989. Advanced Cyclotron Systems Inc. was then formed to develop, promote and sell cyclotrons to the medical community.

Since then, ACSI has been supplying cyclotrons for over 30 years and has always strived to manufacture superior products and lead the way in research and development. ACSI cyclotrons generate the highest production yield and their TR24 was the first commercialized hybrid cyclotron to produce both PET and SPECT isotopes, including Technetium-99. Advanced Cyclotron Systems continues to build on this expertise by producing the highest performing commercial cyclotrons in the world.

“ACSI is very proud of its Canadian roots,” said Alex Zyuzin Director of research and Business Development of ACSI. “We have a reputation as a leader in the global medical isotope community. We manufacture and supply cyclotrons to nuclear medicine markets worldwide, our users include hospitals, universities, research facilities and commercial distributors of medical isotopes. It’s this reputation that has helped to supplant Canada firmly atop the world as a leader in cyclotron technology. To remain in this position, it will take continued work, education and advocacy, which is why we are delighted join the CNIC. Over the past two years the CNIC has established relationships across the industry and been a vocal and visible champion. We are excited to help advance this work and further solidify Canada as an isotope superpower.”

This year, the CNIC is focused on bridging these public and private coalitions into demonstrable results for Canadians, searching for new life-saving cancer treatments. The CNIC will continue to promote public awareness about the use and benefits of medical/industrial isotopes and radiation technologies, and work with government stakeholders to ensure the public policy landscape promotes innovation and supports the increased proliferation of medical and industrial isotope uses.

About the Canadian Nuclear Isotope Council

The CNIC is a coalition of science, health-care and nuclear-sector organizations to ensure Canada remains a world leader in the production of life-saving isotopes by bringing awareness and supporting long-term policies at the domestic and international level that will save countless lives and support health-care innovation for decades to come. To learn more about the CNIC visit and follow us on, Facebook, Twitter, and LinkedIn.

For more information, please contact:
Andrew Thiele
Canadian Nuclear Isotope Council

About Advanced Cyclotron Systems Inc.

Advanced Cyclotron Systems, Inc. (ACSI) is a world leader in the design and manufacturing of cyclotron systems.  With over 30 years of experience and more than 60 cyclotron systems installed, ACSI can provide a wide range of equipment and services worldwide.  ACSI cyclotrons are used for the commercial production and distribution of PET and SPECT nuclides by internationally recognized companies and leading universities and research facilities.  ACSI cyclotrons are designed, manufactured, and assembled in Richmond, Canada.

ACSI offers a full spectrum of cyclotron systems ranging from PET cyclotrons to medium and high energy accelerators. All ACSI manufactured cyclotrons have variable energy and employ external ion source technology, offering the highest beam current output available on the market.

The versatility, high beam current and exceptional quality of ACSI cyclotrons are the reasons why many of the world’s most prestigious universities and research centers, as well as some of the most successful commercial radioisotope producers have chosen ACSI cyclotrons to meet their radioisotope production needs.

For more information, please visit

Our headquarters and manufacturing facility is located in Richmond, BC, Canada.

Alex Zyuzin
Director of research and Business Development at Advanced Cyclotron Systems Inc.